It will improve competition in New Zealand, an obesity doctor says, but can cost up to $900 a month.
For the first time, researchers show that tirzepatide - the active ingredient in the diabetes and weight-loss drug Mounjaro - ...
After the weight-loss drug boom, and with generics closing in, Big Pharma are gearing up for the next game-changer.
Patients on the higher dose of 7.2 milligrams for about 18 months lost 21% of their body weight on average, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results